✦ LIBER ✦

Long-Term Efficacy and Safety of Linagliptin in Patients With Type 2 Diabetes and Severe Renal Impairment: A 1-year, randomized, double-blind, placebo-controlled study

✍ Scribed by McGill, J. B.; Sloan, L.; Newman, J.; Patel, S.; Sauce, C.; von Eynatten, M.; Woerle, H.-J.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety of initial combinati

✍ R. Gomis; R.-M. Espadero; R. Jones; H. J. Woerle; K. A. Dugi 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 849 KB

Safety and efficacy of linagliptin as ad

✍ M.-R. Taskinen; J. Rosenstock; I. Tamminen; R. Kubiak; S. Patel; K. A. Dugi; H.- 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 797 KB

Safety and efficacy of vildagliptin vers

✍ V. Lukashevich; A. Schweizer; Q. Shao; P.-H. Groop; W. Kothny 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 569 KB

Initial combination of linagliptin and m

✍ T. Haak; T. Meinicke; R. Jones; S. Weber; M. von Eynatten; H.-J. Woerle 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 590 KB

A MULTICENTER, DOUBLE-BLIND, RANDOMIZED,

✍ Karthikeyan Ananthasubramaniam; Robert Weiss; Barbara Klauke; Bruce McNutt; Kath 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 243 KB

Efficacy and safety of alogliptin added

✍ K. Kaku; T. Itayasu; S. Hiroi; M. Hirayama; Y. Seino 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 564 KB